EUVIMEDEUVIMED entdecken
Crossref

Screening the effective components of Ficus tikoua on the treatment of lipopolysaccharide induced acute lung injury mice by integrated UHPLC-Q-TOF-MS/MS and network pharmacology

Mengyu Li, Yitang Xu, Mingyu Yang, Xing Jiang, Yingxing Liu, Luxi Lei, Xiang Lu, Xiaoxia Wan, Ye Yang

Journal of Pharmaceutical and Biomedical Analysis · 2026-12 · 281 · 117657

DOI: 10.1016/j.jpba.2026.117657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026-12. Verfasst von Mengyu Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, PR China. Electronic address: limengyu411@163.com. Hauptthemen laut MEDLINE: Acute Lung Injury, Ficus, Plant Extracts, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) is a life‑threatening respiratory disease characterized by excessive inflammation, oxidative stress, and autophagic dysregulation. Traditional Chinese medicine has emerged as a promising strategy for managing respiratory inflammatory conditions. Ficus tikoua Bur. (FT), a well‑known ethnomedicinal prescription used for pneumonia in Guizhou, China, warrants investigation into its effects and mechanisms in ALI. This study integrated UHPLC‑Q‑TOF‑MS/MS chemical profiling, network pharmacology, molecular docking, and lipopolysaccharide‑challenged mouse model to characterize FT's bioactive constituents and therapeutic mechanisms. FT extract (FTE) significantly attenuated lung injury, reduced inflammatory cytokines (TNF‑α and IL‑6), and decreased oxidative stress markers (MPO and MDA). Network pharmacology and molecular docking identified stable interactions between core FT compounds and five key targets (mTOR, AKT1, PIK3CA, PIK3CB, and PIK3CD). Experimental validation further revealed that FTE inhibited PI3K/AKT overactivation, as evidenced by reduced p‑PI3K and AKT expression, while concurrently restoring autophagic homeostasis through downregulation of Beclin‑1 and LC3‑II/I and upregulation of p62. These findings demonstrate that FTE alleviates ALI through coordinated regulation of the PI3K/AKT pathway and autophagic homeostasis. Collectively, this study provides a mechanistic foundation for FT as a multi‑component therapeutic candidate against ALI and offers new perspectives for natural product‑based drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryFicusPlant ExtractsDrugs, Chinese HerbalAnimalsLipopolysaccharidesTandem Mass SpectrometryChromatography, High Pressure LiquidMiceNetwork PharmacologyMolecular Docking SimulationMaleOxidative StressDisease Models, AnimalAutophagyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

Acute lung injuryFicus tikoua Bur.Network pharmacologyUHPLC-Q-TOF-MS/MS

Substanzen

LipopolysaccharidesPlant ExtractsDrugs, Chinese HerbalPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, PR China. Electronic address: limengyu411@163.com.
  • School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, PR China. Electronic address: xuyitang4879@163.com.
  • School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, PR China. Electronic address: yangmingyu5970@163.com.
  • School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, PR China. Electronic address: jiangxing8268@163.com.
  • School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, PR China. Electronic address: liuyingxing1221@163.com.
  • School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, PR China. Electronic address: LucyLei0128@163.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, M., Xu, Y., Yang, M., Jiang, X., Liu, Y., Lei, L., Lu, X., Wan, X., & Yang, Y. (2026). Screening the effective components of Ficus tikoua on the treatment of lipopolysaccharide induced acute lung injury mice by integrated UHPLC-Q-TOF-MS/MS and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis, 281, 117657. https://doi.org/10.1016/j.jpba.2026.117657

Vancouver

Li M, Xu Y, Yang M, Jiang X, Liu Y, Lei L, et al. Screening the effective components of Ficus tikoua on the treatment of lipopolysaccharide induced acute lung injury mice by integrated UHPLC-Q-TOF-MS/MS and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis. 2026;281:117657. doi:10.1016/j.jpba.2026.117657

BibTeX
@article{Li2026,
  author = {Li, Mengyu and Xu, Yitang and Yang, Mingyu and Jiang, Xing and Liu, Yingxing and Lei, Luxi and Lu, Xiang and Wan, Xiaoxia and Yang, Ye},
  title = {Screening the effective components of Ficus tikoua on the treatment of lipopolysaccharide induced acute lung injury mice by integrated UHPLC-Q-TOF-MS/MS and network pharmacology},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2026},
  volume = {281},
  pages = {117657},
  doi = {10.1016/j.jpba.2026.117657}
}
Kostenlos starten →